Previous Article | Next Article ![]()
Journal of Virology, August 2001, p. 7280-7289, Vol. 75, No. 16
Department of Medical Microbiology and
Immunology, University of Göteborg,1 and
Got-A-Gene AB,2 Göteborg, Sweden,
and Laboratoire de Virologie et Pathogénèse Virale,
CNRS UMR-5537, Faculté de Médecine RTH Laennec, 69372 Lyon Cedex, France3
Received 27 December 2000/Accepted 23 May 2001
For efficient and versatile use of adenovirus (Ad) as an in vivo
gene therapy vector, modulation of the viral tropism is highly desirable. In this study, a novel method to genetically alter the Ad
fiber tropism is described. The knob and the last 15 shaft repeats of
the fiber gene were deleted and replaced with an external trimerization
motif and a new cell-binding ligand, in this case the integrin-binding
motif RGD. The corresponding recombinant fiber retained the basic
biological functions of the natural fiber, i.e., trimerization, nuclear
import, penton formation, and ligand binding. The recombinant fiber
bound to integrins but failed to react with antiknob antibody. For
virus production, the recombinant fiber gene was rescued into the Ad
genome at the exact position of the wild-type (WT) fiber to make use of
the native regulation of fiber expression. The recombinant virus
Ad5/FibR7-RGD yielded plaques on 293 cells, but the spread through the
monolayer was two to three times delayed compared to WT, and the ratio
of infectious to physical particles was 20 times lower. Studies on
virus tropism showed that Ad5/FibR7-RGD was able to infect cells which
did not express the coxsackie-adenovirus receptor (CAR), but did
express integrins. Ad5/FibR7-RGD virus infectivity was unchanged in the presence of antiknob antibody, which neutralized the WT virus. Ad5/FibR7-RGD virus showed an expanded tropism, which is useful when
gene transfer to cells not expressing CAR is needed. The described
method should also make possible the construction of Ad genetically
retargeted via ligands other than RGD.
One of the general limitations for
successful gene therapy today is the difficulty of achieving in vivo
gene delivery to specific cells. Among several potent vectors used for
gene therapy is adenovirus (Ad), which benefits from being safe, well
studied, and easy to propagate (46). However, Ad has a
broad tropism and infects a wide variety of cells by binding to the
coxsackie B virus and Ad receptor (CAR) (3) and the major
histocompatibility complex class I alpha-2 domain (16). On
the other hand, cells that do not express these receptors are often
refractory to Ad transduction.
Cellular binding of Ad is mediated by the fiber protein, which is
anchored to the penton bases at vertices of the viral icosahedron. The
fiber is a homotrimer composed of three identical fiber polypeptides arranged in a parallel orientation (39). Trimerization is
absolutely crucial for the fiber to function in attachment both to the
capsid and to the cellular receptor (7) and is achieved by
a trimerization signal that is situated within the knob region
(13, 27), which also contains the ligand that binds to the
cellular receptors (24).
Viral retargeting can be divided roughly into two conceptually
different strategies: (i) nongenetic retargeting and (ii) genetic retargeting involving engineering of viral proteins. Within each group,
expanded as well as narrowed tropism may be achieved. The first
strategy has mainly utilized bispecific antibodies or peptides that
block the native binding of the fiber and redirect the virus to a new
cellular receptor (9, 15).
Efforts using the second strategy include construction of a chimeric
Ad5 fiber with an Ad3 knob (22), modifications of the penton base (43) or hexon proteins (41), and
insertions of new amino acid (aa) motifs in the fiber knob (8,
25). However, the last approach is limited by the fact that the
trimeric nature of the fiber is sensitive to genetic alterations, so
that only small insertions are tolerated. As an example, the C-terminal insertion of 24 aa (25) was tolerated, while 26 aa at the
same position totally disrupted the trimeric structure
(45). Most of the approaches mentioned retain the native
binding structure and thus broaden the viral tropism. For these vectors
to work satisfactorily in vivo, tissue-specific promoters or other
regulatory elements are a necessity unless ablation of the native
cellular binding is achieved. Recently, Kirby et al. (21)
abolished high-affinity binding to CAR by point mutations in the DG
loop of the knob. However, the native conformation of the knob will
still be needed, and large insertions in flexible loops such as DG or
HI might be as badly tolerated as in the rest of the knob. It is
therefore unlikely that the use of nonbinding fiber-knobs as molecular
scaffolds or frameworks for new cell-binding ligands will be widely
useful for the construction of genetically retargeted Ad.
The aim of this study was to genetically retarget Ad and simultaneously
remove the cell-binding ligand. In contrast to the earlier concept of
preserving and modifying the knob, we have "deknobbed" the fiber by
removing the fiber sequence C-terminal of the seventh shaft repeat.
This completely removes the cell-binding ligand but also the
trimerization signal. To compensate for the loss of trimer formation,
we inserted the neck region peptide (NRP) of human lung surfactant
protein D as an external trimerization signal. This 36-residue motif
self-assembles into an extremely strong, tightly associated, parallel
three-stranded (Construction of knobless fibers with a new trimerization signal and a
new cell-binding ligand was described by L.L. at the Cold Spring Harbor
meeting on Vector Targeting Strategies, 1997.)
Cells.
HEK-293 cells (11) were purchased from
Microbix (Toronto, Ontario, Canada) and Cos7 cells, RD cells, and HeLa
cells were obtained from the American Type Culture Collection (ATCC,
Rockville, M.). All cultures were maintained in Iscove's medium
(Gibco-BRL) supplemented with 10% fetal bovine serum (Sigma-Aldrich)
and gentamicin (50 µg/ml) (Gibco-BRL) at 37°C and 5%
CO2. Spodoptera frugiperda Sf9 cells (ATCC) were
propagated in TC100 medium (Gibco-BRL) with the abovementioned
supplements at 28°C.
Antibodies.
Three monoclonal fiber antibodies were
obligingly supplied by Jeff Engler (University of Alabama at
Birmingham). Antibody 4D2.5 recognizes the conserved linear motif
FNPVYP found in most Ad fiber tails (13, 14); 2A6.36 is
specific for a conformational epitope present in fiber trimers within
residues 17 to 61, as suggested by deletion mapping (13)
and the lack of reactivity with trimers of our deletion mutant AT61
(27); 1D6.14 is an antiknob, CAR-binding blocking antibody
(32) whose epitope has been mapped within residues 471 to
491 (unpublished data). Fluorescein isothiocyanate (FITC)-labeled
rabbit anti-mouse immunoglobulin G (IgG) and streptavidin-horseradish
peroxidase (HRP) were purchased from Dako.
Anti- Construction of recombinant fibers.
The wild-type (WT) fiber
gene was amplified from pAB26 (Microbix) using the primers 5'-CTC
GGA TCC GAT GAA GCG CGC AAG ACC GTC TGA A-3' (5' oligonucleotide)
and 5'-TTC CTC GAG TTA TTC TTG GGC AAT GTA TGA-3' (3'
oligonucleotide), introducing an upstream BamHI and a
downstream XhoI site, respectively (Fig.
1). Recombinant fibers containing the
tail, different numbers of shaft repeats (1, 7, or 22) followed by the
external trimerization signal NRP (PDVASLRQQVAELQGQVQHLQAAFSQYKKVELFPNG) (17), a
linker sequence from Staphylococcus protein A
(AKKLNDAQAPKSD), and RGD were constructed by PCR
amplification of the WT fiber gene, followed by splicing by overlap
extension and ligation, which introduced the flanking restriction sites
mentioned above (detailed information can be requested from the
authors). A recombinant fiber with seven shaft repeats and the
disulfide bond-containing, constrained ligand RGD4C (ACDCRGDCFCG)
(30) was also constructed for comparison to the
linear RGD motif. The fibers were named R1-RGD, R7-RGD, R7-RGD4C, and
R22-RGD (Fig. 1), respectively, indicating the different numbers of
shaft repeats preceding the cell ligand. NRP was ligated to the first
repeat at the SphI site, the seventh repeat at the NheI site, and the 22nd repeat after the conserved TLWT
motif at positions 400 to 403.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7280-7289.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Genetic Retargeting of Adenovirus: Novel Strategy
Employing "Deknobbing" of the Fiber
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-helical bundle (17). In its original
lung surfactant protein D context, NRP is flanked N-terminally by
collagen regions and C-terminally by C-type lectin domains, suggesting
that complex structures can be placed C-terminally of NRP without
disrupting the ability to trimerize. As a proof of concept, we placed
the short peptide motif arginine-glycine-aspartic acid (RGD) at the
C-terminal end of the fiber for binding to cell surface integrins
v
3 and
v
5 (44) and showed that these recombinant fibers could be
rescued into functional, infectious, retargeted virions.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
v
3 integrin (LM609) and
anti-
v
5 integrin (P1F6) monoclonal
antibodies were from Chemicon International, Inc. The monoclonal
antibody RL2, which is specific for O-linked GlcNAc residues
(26), was obtained from Larry Gerace via Jeff Engler. Antihexon capsomers were produced by the 2Hx2 hybridoma, purchased from ATCC.

View larger version (37K):
[in a new window]
FIG. 1.
Schematic representation of the WT fiber and recombinant
fibers R22-RGD, R7-RGD (or RGD4C), and R1-RGD. The tail fiber domain is
shown by a stippled box, the shaft by a solid box, and the knob domain
by a hatched box. Additional structural and functional motifs in
recombinant fibers, i.e., extrinsic trimerization signal (NRP), linker
peptide, and cell ligand RGD or RGD4C, are represented as indicated in
the diagrams. The fiber sequence ends at aa M-61 in R1-RGD, K-156 in
R7-RGD, and T-403 in R22-RGD.
Protein expression and purification. For analysis of cellular localization in mammalian cells, recombinant fibers were cloned into pcDNA3.1 (Invitrogen, San Diego, Calif.), and Cos7 cells were transfected using Lipofectamine (Life Technologies Inc., Gaitherburg, Md.) according to the protocol of the manufacturer. Two days posttransfection, the cells were harvested, centrifuged onto cytospin slides, and dried overnight. Immunofluorescent staining was performed after fixation in 3% paraformaldehyde and permeabilization in 0.1% Triton X-100 in phosphate-buffered saline (PBS). The primary antibodies 4D2.5 and 2A6.36 were used as ascites fluids diluted to 1:1,000, while the secondary FITC-labeled anti-mouse Ig antibody was used at a dilution of 1:10. Each antibody was incubated with the specimens for 30 min at 37°C. Expression and nuclear localization were observed using a Zeiss Axioskop fluorescent microscope and photographed with a Zeiss automatic camera at ×40 magnification.
For protein production and purification, the genes coding for fibers, WT penton base, and penton base mutant R340E (19, 20) were cloned into the baculovirus Autographa californica nuclear polyhedrosis virus, using the pBacPAK9 (Novagen) or BacPAK6 (Clonetech) vector. Recombinant Ad proteins were expressed in Sf9 cells and purified according to a previously described method (5), with some modifications. The anion-exchange chromatographic step was performed using a high-performance liquid chromatography system (BioLogic DuoFlow; Bio-Rad) and a DEAE-Sepharose Fast Flow column (DFF-100; Sigma) equilibrated in 50 mM sodium phosphate buffer, pH 6.8 (PB-50). Samples (2 to 3 mg of protein) were applied to the column, and elution was obtained by applying a 0.0 to 0.6 M NaCl gradient in PB-50. Fiber protein was eluted at 200 mM salt and penton base at 250 mM salt, respectively. Protein samples were then further purified and concentrated using concentrator membranes with a 100-kDa cutoff (Vivaspin-100; Vivascience Ltd, Binbrook, Lincoln, England). Final protein concentration was estimated using the Bradford assay (Bio-Rad).Phenotypic analysis of fiber proteins. Recombinant fiber proteins were phenotypically analysed for their trimerization, glycosylation, and assembly in Sf9 cells with recombinant penton base to form complete pentons. Oligomerization was assayed by means of nondenaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (NDS-PAGE) and by conventional, denaturing SDS-PAGE. NDS-PAGE differed from SDS-PAGE in that the samples were not denatured by boiling in SDS sample buffer prior to electrophoresis. Glycosylation of recombinant fibers was assessed both by immunoreaction on blots using the monoclonal antibody RL2 and by chemical detection using the DIG Glycan detection kit (Roche). Assembly of fiber with penton base to form penton in vivo was assayed by coinfecting the same Sf9 cells with two recombinant AcNPV, one expressing the penton base and the other expressing the fiber protein. The presence of penton capsomer was detected in cell lysates 40 h postinfection and analyzed by PAGE in native conditions at low voltage overnight with cooling, as previously described (19). For immunological quantification of native penton, penton base, and fiber proteins, blots were reacted with the corresponding primary antibody (anti-penton base or antifiber), followed by [35S]SRL-labeled anti-mouse or anti-rabbit whole IgG secondary antibody (Amersham Pharmacia Biotech; 100 µCi/ml; 5 µCi per blot). Blots were exposed to radiographic films (Hyperfilm Beta-max; Amersham Pharmacia Biotech), and autoradiograms were scanned at 610 nm using an automatic densitometer (REP-EDC; Helena Laboratories, Beaumont, Tex.). Alternatively, protein bands were excised from blots and radioactivity was measured in a scintillation counter (Beckman LS-6500), as previously described (18).
ELISA.
Integrins
v
3 and
5
1 (Chemicon) at 1 µg/ml in coating
buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 2 mM CaCl2,
1 mM MgCl2, 1 mM MnCl2) was used to coat
96-well plastic plates for 16 h at 4°C. After one wash in
rinsing buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 2 mM
CaCl2, 1 mM MgCl2, 1 mM
MnCl2), the plates were blocked with 200 µl of blocking
buffer (rinsing buffer containing 4% nonfat dried milk) at room
temperature for 2 h. Wells were then washed three times with
rinsing buffer. Five-step dilutions (1 to 0.008 µg/ml) of recombinant
fibers in blocking buffer were added to the wells in 100 µl for
1 h at room temperature. Detection of bound fibers was done with 1 µg of 4D2.5 (biotinylated and protein A purified), streptavidin-HRP
diluted 1:2,000, and TMB substrate (CanAg Diagnostics, Göteborg,
Sweden) per ml. Color development was stopped with 0.12 M HCl after 10 min, and plates were analyzed in a microtiter plate reader set at 450 nm.
Generation of recombinant Ad genomes.
To generate
recombinant Ad5 genomes, a fiber shuttle vector and a fiber rescue
plasmid were constructed using pTG3602, a plasmid which contains the WT
Ad5 genome with PacI restriction sites at both ends
(6). This is schematically depicted in Fig. 4. To construct the shuttle vector, the SacI-KpnI
fragment of 3.4 kb from 84.0 to 93.5 map units (mu), which contains the
fiber gene, was cloned into pBluescript II SK(
) (Stratagene). The
fiber gene was then deleted from the NdeI site, located in
the fiber tail, to the MunI site, present a few nucleotides
downstream of the fiber gene. The deleted region was replaced by an
annealed oligonucleotide linker constituted of an XhoI site
flanked by an NdeI site and a MunI site at its 5'
and 3' ends, respectively. The resulting shuttle plasmid was referred
to as pGAG3. For construction of the fiber rescue plasmid, pBluescript
II SK(
) was first supplied with a PacI site. Thereafter,
the SpeI-PacI fragment of 8.8 kb (75.4 to 100 mu)
from pTG3602 was ligated to the pBluescript II SK(
) PacI
site to generate pGAG9.
Virus generation. Recombinant cosmid DNA was restricted with PacI, precipitated with ethanol, and resuspended in sterile H2O. Transfection into 293 cells was performed using FuGENE (Roche) according to the manufacturer's recommendations, with 2 µg of DNA and 3 µl of FuGENE in each 35-mm well. Large-scale production and CsCl gradient purification of virus were performed as previously described (10). The presence of fiber genes in virions was analyzed by PCR with primers specific for the WT and recombinant fibers. The presence of fiber proteins in virions was determined by Western blot analysis with 4D2.5 antitail antibody. Expression of GFP in infected cultures was verified by UV microscopy using a Zeiss Axioskop fluorescent microscope. Infectious titers (PFU per milliliter) were determined by plaque titration on 293 cells using an endpoint dilution method (29), and the number of physical virus particles was determined using the IDEIA Ad detection kit (Dako). The rate of virus growth was determined as follows. 293 cells (4 × 104) were infected with WT or recombinant virus at 10 PFU/cell for 1 h at 37°C. After rinsing with PBS, complete medium was added and cell samples were harvested at 24, 48, and 72 h after infection. Cell pellets were washed in PBS, resuspended in 200 µl of PBS, and freeze-thawed four times. The cell lysates were assayed for production of Ad5 proteins by the IDEIA kit, and the infectivity titer, determined by plaque titration on 293 cells as above, was plotted versus the time of infection.
Quantitative analysis of fiber content of virions. 293 cells in 24-well plates were washed once with Iscove's medium and infected with 10 PFU/cell in 100 µl of Iscove's medium. After 1 h at 37°C, the cells were washed in complete medium (Iscove's medium with 10% fetal bovine serum and 50 µg of gentamicin per ml) and incubated with complete medium at 37°C and 5% CO2. Cells were harvested at 24, 48, and 72 h postinfection, collected in 0.2 ml of Iscove's medium, and freeze-thawed four quick rounds to release virions. Virus titer was determined by plaque assay in 293 cells, and viral proteins were assayed using the IDEIA kit. Western blots of the freeze-thawed material and CsCl-purified virus were reacted with 4D2.5 and 2Hx2 to assay the fiber versus hexon content, and quantification was performed using the Scion Image program.
Gene transfer assay. Monolayers of HeLa and RD cells in 24-well plates were infected as described above with 10 PFU of the recombinant viruses per cell, with or without different blocking agents. The antiknob antibody 1D6.14 was used at concentrations ranging from 0.001 to 10 µg/ml. Virus and antibody were mixed and diluted to 0.1 ml in Iscove's medium and incubated for 1 h at 37°C before cell infection, as above. The cells were examined by immunofluorescence (IF) microscopy at intervals during the course of infection for the appearance of GFP fluorescence. For fluorescence-activated cell sorting (FACS) analysis, the cells were harvested at 24 h postinfection and washed with ice-cold PBS, followed by fixation with 0.5% glutaraldehyde for 15 min. After three washes in PBS, the cells were analyzed for GFP expression using the FL1 emission channel in a FACScan cytometer (Becton Dickinson, San Jose, Calif.).
| |
RESULTS |
|---|
|
|
|---|
Phenotypic characterization of recombinant fibers with different shaft lengths. The number of shaft repeats in fiber determines the shaft length (33) and has important implications in receptor usage (31, 38). Fiber proteins with various numbers of shaft repeats were thus compared (Fig. 1). Fiber with one single repeat (R1-RGD) was constructed to test a very short fiber; fiber with seven repeats (R7-RGD) resembled the short-shafted Ad3 fiber; and fiber with 22 repeats (R22-RGD) mimicked the Ad5 WT fiber shaft. The choice of the number of shaft repeats for the fiber of retargetable Ad5 vectors was guided by the results of phenotypic analysis of the different fiber constructs. The recombinant fibers were expressed in both mammalian and insect cells and phenotyped according to the following criteria: (i) their cellular localization, (ii) the occurrence and stability of fiber trimers, (iii) their capacity to form penton capsomers in insect cells coinfected with a recombinant baculovirus-expressing penton base, and (iv) their glycosylation status.
(i) Cellular localization and fiber trimerization. The cellular localization and trimer status of the recombinant fibers were studied by transient expression in Cos7 cells at 48 h after transfection. The cells were fixed, reacted with monoclonal antibodies specific for fiber tail (4D2.5) and fiber trimers (2A6.36), and examined by IF microscopy. The IF patterns observed showed that all our recombinant fiber proteins were well expressed and localized in the nucleus. They were all capable of forming trimers, just like the WT fiber (data not shown).
The trimerization status was also tested by electrophoresis and Western blotting of fiber samples denatured by boiling in SDS (SDS-PAGE) or unboiled (nondenatured; NDS-PAGE). The NDS-PAGE pattern for unboiled recombinant WT fiber consisted of three distinct protein species, monomers, dimers, and trimers (Fig. 2A, lane 3). For recombinant fibers R7-RGD and R22-RGD, dimers and trimers were similarly observed (Fig. 2 A, lanes 7 and 9). However, the oligomeric forms of R22-RGD were barely visible, since the R22-RGD clone was a low expressor in terms of soluble fiber protein (data not shown). In the case of R1-RGD, no trimers were visible in NDS-PAGE, and all detectable fiber occurred in monomeric form (Fig. 2A, compare lanes 4 and 5). However, in gel electrophoresis under native conditions, in the absence of SDS, fiber trimers were detected for all the recombinants, including R1-RGD, using the antitrimer antibody 2A6.36 (data not shown). Moreover, R1-RGD fiber reacted positively with 2A6.36 within the cell, as shown by IF microcopy. This strongly suggested that R1-RGD fiber did form trimers in vivo but that these trimers were unstable in vitro in the presence of SDS, even at low temperature.
|
(ii) Assembly with penton base to form penton capsomers. In vivo in coinfected Sf9 cells, all our recombinant fibers were able to assemble with penton base to form penton capsomers, which were detectable in gels electrophoresed under native conditions (Fig. 2B and C). Free fiber trimers migrated in the native gel as polydispersed molecules visible as a smear on immunoblots (Fig. 2B), whereas penton capsomers appeared as a sharp, slow-migrating band (Fig. 2B and C). This discrete larger protein species was revealed by both fiber and penton base antibodies, confirming that they were penton complexes (Fig. 2B and C).
The efficiency of penton assembly with our recombinant fibers was quantitatively estimated by immunoblotting of Sf9 cell lysates electrophoresed in native gels, using fiber and penton base antibodies and the corresponding radioactively labeled secondary antibody. The radioactivity was measured and compared for the penton capsomer band and the free fiber band in blots probed with antifiber antibody (Fig. 2B) or for the penton capsomer band and the free penton base band in blots probed with anti-penton base antibody (Fig. 2C). The data are shown in Table 1. With WT fiber, which is highly expressed in insect cells (27), only 5% of the fiber assembled with penton base, while the rest remained as free fiber trimers, and the penton base often appeared to be the limiting factor for penton assembly (Fig. 2C, lane 3). With R1-RGD, R7-RGD, and even R22-RGD fiber, assembly with penton base seemingly occurred with a higher efficiency and/or greater stability than with WT fiber (Table 1 and Fig. 2B, compare lanes 3, 4, 5, and 6). This would suggest that penton constituted of knobless fiber and containing the NRP trimerization signal would be more stable than WT penton capsomers constituted of penton base and full-length, knob-terminated fiber, at least in insect cells. It has already been suggested that the fiber knob domain could be responsible for a certain degree of flexibility or instability in Ad2 penton capsomer (4, 14).
|
(iii) Glycosylation status of recombinant fibers. None of our recombinant RGD fibers showed any detectable O-GlcNAc signal, as assayed by two different methods, Western blot analysis using RL2 antibody specific for peptide-linked O-GlcNAc residues and a biochemical assay using the DIG Glycan detection kit. Only WT fiber was found to be glycosylated (data not shown). This suggested that O-GlcNAc residues were dispensable for most of the known biological functions of the fiber.
Thus, considering that R22-RGD fiber was expressed at low levels and that R1-RGD self-assembled into rather unstable fiber trimers, R7-RGD was retained as the most favorable knobless fiber construct to be reintroduced into the viral genome for the generation of knobless Ad5 vectors. Further characterization therefore concerned R7-RGD fiber and R7-RGD-containing virions.Functionality and binding specificity of fiber proteins.
The
binding function of WT and R7-RGD fibers was examined by
solid-phase enzyme-linked immunosorbent assay (ELISA). Both fibers were
tested for binding to antiknob monoclonal antibody 1D6.14 and integrin
v
3. WT fiber was found to bind with a
high affinity to the knob antibody compared to the absence of
significant binding by the R7-RGD fiber (Fig.
3A). The reverse was observed with wells coated with
v
3 integrin; WT fiber showed
no detectable binding, while R7-RGD fiber had a high affinity for
v
3 integrin (Fig. 3B). The specificity of
binding of the R7-RGD fiber to immobilized integrin
v
3 was also studied by ELISA in the
presence of RGD peptides or penton base proteins as competitors. RGD
peptides competed poorly with R7-RGD fiber for integrin binding (data
not shown), probably due to a low stability of the integrin-RGD
complexes in ELISA. However, WT penton base, which carries five RGD
motifs, competed efficiently (Fig. 3C). In contrast, penton base mutant R340E, mutated in the RGD motifs (20), failed to compete
with R7-RGD fiber, suggesting that the competition of WT penton base with R7-RGD fiber was RGD specific (Fig. 3C). Binding of WT and R7-RGD
fibers was also tested on
5
1 integrins
(data not shown), and the assays gave similar results as for
v
3 integrin. Thus, our results suggested
that the R7-RGD fiber had lost its affinity for the knob antibody but
had gained the ability to bind to
v
3 and
5
1 integrins. This implied that the RGD
motif on the fiber was in the proper conformation and accessible for
binding to cell surface-exposed
v
3 and
5
1 integrins.
|
Rescue of functional recombinant fiber genes into infectious
virions.
To generate virions with modified fibers, a strategy was
designed to insert the recombinant fiber gene exactly in the position of the fiber gene in the Ad5 chromosome so as to make use of the native
regulation of fiber gene expression. This was achieved by a three-step
rescue system (Fig. 4), in which the
recombinant fiber was first cloned into the shuttle vector pGAG3
containing the tail and the flanking sequences of the fiber gene. As a
negative control, the empty pGAG3 vector was used. The fragments were
then rescued into pGAG9 (75.4 to 100 mu of the WT Ad5 genome) by
homologous recombination in E. coli BJ5183. As a final step,
cosmid cloning was used for ligation to the rest of the genome. For
convenient detection of gene transfer, our recombinant Ad genome
contained the GFP reporter gene cloned under the control of the CMV
promoter in the deleted E1 region. The resulting genome was joined at
both ends to the cosmid backbone by PacI and could thus be
recovered as a linear DNA fragment after cleavage with PacI
and transfected into cells to yield virus. On the average,
approximately 20% of the cosmid colonies contained the expected
recombinant Ad5 genome.
|
Efficiency of virus propagation. After transfection of 293 cells, approximately 8, 16, and 16 days elapsed before plaques appeared for the viruses designated Ad5/FibWT, Ad5/FibR7-RGD, and Ad5/FibR7-RGD4C, respectively. The genome with the deleted fiber did not give any plaques. The recombinant viruses were then amplified in 293 cells, and the viruses were purified by ultracentrifugation in a self-generating CsCl gradient. After virus purification, the fiber genotype was controlled and confirmed by PCR amplification and DNA sequencing, using primers specific for WT and R7-RGD fibers. In addition, the presence of fiber proteins in virions was assayed immunologically by Western blot analysis using antifiber antibody. Although the expected fiber sequence and signal were found in our virus constructs, Ad5/FibR7-RGD and Ad5/FibR7-RGD4C virus spread through cellular monolayers occurred at a two to three times slower rate compared to Ad5/FibWT.
Comparison of the infectivity index of WT and recombinant virus showed that Ad5/FibR7-RGD was 20 times less infectious than Ad5/FibWT; the ratio of infectious particles (detected by fluorescent plaques and expressed as PFU) to physical particles (estimated by biochemical methods) was found to be 1:25 for Ad5/FibWT, versus 1:500 for Ad5/FibR7-RGD. Analysis of growth curves in 293 cells showed that Ad5/FibWT and Ad5/FibR7-RGD virions grew at similar rates in a complementing cell line and synthesized similar amounts of viral proteins. However, the plateau of infectious progeny yields for Ad5/FibR7-RGD was 100-fold lower than for Ad5/FibWT (Fig. 5).
|
Fiber content of recombinant Ad5 virions.
To further
investigate the difference in virus propagation between Ad5/FibR7-RGD
and Ad5/FibWT, 293 cells were infected with aliquots (10 PFU/cell) of
each virus. The cells were harvested at different times postinfection
and lysed, and the virus proteins released were assayed in the
supernatants. At all time points the infected cells appeared
identical, as judged visually. The IDEIA assays showed that similar
amounts of viral proteins were produced by Ad5/FibR7-RGD- and
Ad5/FibWT-infected cells. Protein analysis of cell lysates showed
similar amounts of hexon yields, while probing for fiber revealed about
10 times less R7-RGD fiber compared to WT fiber (data not shown).
CsCl-purified viruses were also probed for fiber and hexon contents in
virus samples normalized for physical particle number and infectious
particle number, respectively (Fig. 6).
The results showed that similar amounts of fibers were found when
Ad5/FibR7-RGD and Ad5/FibWT virus samples were normalized for
infectious particles (as counted on 293 cells; Fig. 6, top panel,
compare lanes 1 and 2). However, when virus samples were normalized for
physical particles (assayed by hexon content; Fig. 6, lower panel),
significantly fewer fibers were present in the Ad5/FibR7-RGD than
in the Ad5/FibWT sample (Fig. 6, top panel, compare lanes 3 and 4). As
shown by quantitative analysis, the difference ranged within 10- to
40-fold, depending on virus preparations. This result implied that
there was a lower fiber copy number per virion in Ad5/FibR7-RGD or,
alternatively, that the Ad5/FibR7-RGD virus preparation contained a
mixture of fiberless particles with low infectivity (23)
and fully infectious virions with normal fiber content.
|
Cell specificity of gene transfer mediated by recombinant Ad5.
To evaluate the tropism of the recombinant viruses, the efficiency of
Ad5-mediated gene transfer to HeLa cells and RD cells was assayed in
the presence and absence of antiknob antibody. CAR is known to be
expressed by HeLa cells but not by RD cells if they are passaged and
grown to low cell density (37). The integrin
v
5 was found to be expressed on HeLa
cells, and both
v
3 and
v
5 integrins were found on RD cells, as
detected by FACS analysis after staining with specific monoclonal
antibodies (data not shown). The infectivity of Ad5/FibWT and
Ad5/FibR7-RGD was determined in both HeLa and RD cells (Fig.
7). As expected, HeLa cells were fully
susceptible to both Ad5/FibWT and Ad5/FibR7-RGD viruses, whereas RD
cells were found to be only permissive for Ad5/FibR7-RGD and poorly
permissive for Ad5/FibWT. To verify that cell binding of Ad5/FibR7-RGD
virus was not dependent on the knob receptor, CAR-blocking experiments
were performed using 1D6.14 antibody. As shown in Fig.
8, the Ad5/FibWT virus was readily blocked by the antiknob antibody in a dose-dependent manner, while the
antibody had no effect on the Ad5/FibR7-RGD virus.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This study presents a new concept for genetic retargeting of Ad and demonstrates its utility for gene transfer into cells lacking the CAR receptor. The main feature in the present reconstruction of the fiber gene is to genetically delete the fiber of its native binding specificity and to replace this with a new ligand in order to retarget the virus to a new cellular receptor. However, in order for Ad fibers to be properly assembled into functional proteins and be encapsidated into infectious virions, several requirements have to be fulfilled. For example, the fibers need to be able to form parallel homotrimers, to bind to penton base via its tail region to form penton capsomers, to localize within the correct cellular compartment, i.e., the nucleus, where capsid assembly occurs, and lastly, in the context of the virion, to cellular receptors.
The genetically modified knobless fibers that we have constructed here were designed to meet the abovementioned requirements. As evaluated from the results obtained, it seemed feasible to compensate for the lack of biological functions carried by the fiber knob at the virion level by inserting an extrinsic trimerization motif and a new cell ligand which completely changed the tropism of the virus. We introduced a 36-aa peptide from the human lung surfactant protein D (NRP) as an extrinsic trimerization motif and an RGD peptide as a cell ligand. To allow more flexibility and accessibility, a linker sequence from Staphylococcus protein A was inserted between the NRP and the cell surface ligand RGD. The recombinant fibers could be made to contain different numbers of shaft repeats. We have been able to generate infectious viruses with functional fibers containing one and seven shaft repeats (this study), as well as three and five repeats (unpublished results), but not with recombinant Ad5 fibers containing the full-length shaft (22 repeats). This was in apparent contradiction to a recent work which showed the rescue of knobless, His-Myc epitope-tagged, full-length fibers into virions (40). However, the authors had cotransfected cells with a plasmid expressing both WT fiber and a knobless, full-length fiber construct, and both fibers were thus rescued into chimaeric Ad5 virions with two distinct fiber species, WT and knobless mutant. This difference in strategy could explain the yield of infectious virus progeny using knobless full-length fibers. Among several of our shortened fiber constructs, the knobless fiber with seven shaft repeats (R7) and an RGD peptide motif at its C terminus (linear, as in R7-RGD, or constrained, as in R7-RGD4C), was found to be the one which retained the essential functions of the fiber while carrying a new cell-binding specificity. The reason for this observation is presently under investigation, but it constitutes the rationale for the use of R7 fibers in the present work.
The recombinant R7-RGD fiber was found to bind to
v
3,
v
5, and
5
1 integrins. As shown previously using
different approaches, the RGD motif has the ability to target Ad
virions to otherwise refractory cell lines after being incorporated
into the fiber or the hexon protein (8, 41). The failure
to block the virus with the antiknob antibody further demonstrated that
Ad5/FibR7-RGD was not longer dependent on the CAR receptor for cell
attachment and infection. The recombinant Ad5/FibR7-RGD and
Ad5/FibR7-RGD4C viruses may therefore be used as gene transfer vectors
for cells expressing integrins but not CAR (Fig. 7), thereby broadening the tropism of Ad vectors. Since the integrin ligand motif RGD is also
present in the penton base (1, 2, 44), it was legitimate
to ask to what extent penton base RGD could contribute to the cellular
integrin binding of Ad5/FibR7-RGD, considering that the fibers are
shortened and the RGD in penton base could theoretically protrude
approximately to the top of the shortened fiber (36, 42).
Although the participation of penton base RGD could not be excluded,
some arguments suggested that the major cell-binding determinants for
Ad5/FibR7-RGD still resided in its recombinant fiber capsomer. (i)
Fiberless virions have been reported to be far less infectious than WT,
with 10,000-fold difference in infectivity (23). In our
case, Ad5/FibR7-RGD and Ad5/FibWT showed only a 20-fold difference in
infectivity. (ii) When the RGD motif was replaced by the sequence of
epidermal growth factor (EGF) in R7 fiber, no viable Ad5/FibR7-EGF
virus could be isolated, although R7-EGF recombinant fiber
self-assembled into trimers which were detected in penton complexes
(Magnusson et al., unpublished data). This suggested that RGD in penton
base could not compensate for the lack of initial cell binding of the
virus via the fiber.
As mentioned in the Results, the amount of viral capsid proteins synthesized after infection with the same multiplicity of infection (equal number of PFU/cell) was equivalent for viruses containing the WT fiber and the R7-RGD fiber, although their respective infectivities were significantly different. Several hypotheses could be proposed to explain the 20-fold difference in infectivity between Ad5/FibWT and Ad5/FibR7-RGD viruses. (i) A lower ability for recombinant fibers to assemble with penton base compared to WT fiber and/or a lower stability of penton capsomers containing the knobless R7 fibers would be unlikely on the basis of their efficient assembly with coexpressed recombinant penton base in insect cells (Fig. 2B and C). (ii) Likewise, the recombinant fibers used in our study were C-terminally truncated, and it has been suggested that deletion of portions of the fibers could remove some function(s) necessary for virus maturation (23, 42). However, we have also constructed R7 fibers with ligands other than RGD which yield viruses that are as infectious as WT virus (Strand et al., unpublished data). This suggested that the reduction in shaft length to seven repeats does not per se seem to significantly impair the capacity of the virus to infect cells or that the influence of shaft length can vary with the ligand used.
(iii) At late times postinfection, Ad5/FibR7-RGD-infected cells yielded significantly lower levels of R7-RGD fiber than WT Ad5-infected cells (about 10-fold less), and the Ad5/FibR7-RGD virus samples contained 10 to 40 times fewer fibers per virion than WT Ad5 (Fig. 6). The low R7-RGD fiber content of infected cells was unexpected, since the tail and all the sequences upstream of the fiber gene were left intact in order not to disturb the normal regulation of fiber expression. However, if R7-RGD fiber protein was present in limiting amounts, this could negatively affect both the equilibrium of the penton assembly reaction (5) and the overall fiber content of the virus. The resulting lower number of cell-binding sites in the recombinant virus would in turn contribute to the lower infectivity of Ad5/FibR7-RGD. (iv) Even though there was a direct relationship between the low fiber content of recombinant viruses and the low fiber yields of Ad5/FibR7-RGD-infected cells, the molecular mechanisms behind the latter remain unclear. It has been suggested that O-GlcNAc might be important for Ad2 and Ad5 fiber assembly and stabilization (26), and a major O-GlcNAc site has been mapped within residues 61 and 410 of the Ad2 fiber shaft (27). Further deletion mapping analyses have narrowed down the site(s) to within residues 61 to 260 (13), then to 61 to 216 (35). Our biochemical and immunological analyses showed that recombinant knobless R7-RGD fibers expressed in Sf9 cells and the ones encapsidated into virions were not glycosylated, suggesting that both lacked a functional O-glycosylation site(s) from residues M-1 to K-156. Although most of the known functions assumed by the fiber were still apparently effectuated by our R7-RGD fiber, it could not be totally excluded that its lack of O-glycosylation would have altered one of its subtle but critical biological properties.
(v) Results from a recent comparative study of infectivity of Ad containing fiber shafts of various lengths suggested that the observed weak cell attachment of short-shafted fiber-containing Ad vectors could be due to repulsive acidic charges carried by the Ad capsid and present on the cell surface (38). (vi) Another factor that may affect the ability of RGD-targeted viruses to infect cells is the efficiency of the interaction between fiber RGD and cellular integrins in promoting virus entry (31). It has been reported (44) that the interaction between the fiber and CAR has a 30-fold-higher affinity than the penton-integrin interaction. Furthermore, the particular context in which the RGD is presented to integrins might largely influence the binding (34). It is therefore possible that other RGD-containing peptides incorporated into the fiber would yield more efficient or competent viruses than the present ones. A comparison between RGD and RGD4C fibers, which may differ in this regard, is under way. (vii) In the same line of reasoning, it is very possible that at the multiplicity of infection used with the Ad5/FibR7-RGD recombinant, surface integrins were approaching saturation with the RGD peptide in the fiber. This would lead to reduced ability of the penton RGD to interact with another integrin molecule, precluding viral penetration. Thus, at 10 PFU/cell, equivalent to 5,000 physical particles of Ad5/FibR7-RGD per cell, and based on a theoretical full copy number of fiber and penton base subunits in intact Ad5/FibR7-RGD capsids (i.e., with 12 complete apex structures), a total of 180,000 RGD/cell (5,000 × 12 × 3) would be presented by the fiber projections and 300,000 RGD/cell (5,000 × 12 × 5) would be presented by the penton base capsomers. (viii) These hypotheses are not mutually exclusive, and the factors described in iii, iv, v, vi, and vii could combine and account for the lower infectivity of Ad5/FibR7-RGD compared to WT Ad5.
It is our hope that the radical fiber-engineering approach described in this study will enable insertions of larger ligands than those that are tolerated by the native fiber knob, for example, single-chain antibodies and other complex, folded binding structures. This could be reasonably envisaged, given that conditions for correct domain folding are maintained in our recombinant fiber constructs harboring the trimerization motif NRP. Indeed, in its natural environment within the human lung surfactant protein D, NRP is bordered by N-terminal collagen regions and C-terminal C-type lectin domains (17), two domains which have structural and functional similarities with the shaft and knob domains, respectively. Our novel approach to genetic retargeting of Ad could then open up new possibilities for gene therapy.
| |
ACKNOWLEDGMENTS |
|---|
The work in Gothenburg (M.K.M. and L.L.) was supported by the Swedish Medical Research Council (grant no. K98-06X-12624-01), the Swedish Cancer Society (grant no. 0512-B99-12XCC), and the IngaBritt and Arne Lundberg Foundation (grant no. 205/96) and by grants from Got-A-Gene AB, Gothenburg, Sweden. The work in Lyon (S.S.H. and P.B.) was financially supported by the French Ministère de la Recherche et de la Technologie (PRFMMIP AO-98) and the French Foundation for Cystic Fibrosis (Vaincre la Mucoviscidose).
The expert technical contribution of Elisabeth Pettersson and Petra Strand is gratefully acknowledged. Bert Vogelstein is thanked for the generous supply of the vectors pAdEasy and pAdTrack.
| |
ADDENDUM IN PROOF |
|---|
After submission of the manuscript, an article taking a similar approach was published by Krasnykh et al. (V. Krasnykh, N. Belousova, N. Korokhov, G. Mikheeva, and D. T. Curiel, J. Virol. 75:4176-4183).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medical Microbiology & Immunology, University of Göteborg, P.O. Box 435, SE-405 30 Göteborg, Sweden. Phone: 46-31-3424693. Fax: 46-31-415608. E-mail: leif.lindholm{at}microbio.gu.se.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bai, M.,
B. Harfe, and P. Freimuth.
1993.
Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells.
J. Virol.
67:5198-5205 |
| 2. |
Belin, M. T., and P. Boulanger.
1993.
Involvement of cellular adhesion sequences in the attachment of adenovirus to the HeLa cell surface.
J. Gen. Virol.
74:1485-1497 |
| 3. |
Bergelson, J. M.,
J. A. Cunningham,
G. Droguett,
E. A. Kurt-Jones,
A. Krithivas,
J. S. Hong,
M. S. Horwitz,
R. L. Crowell, and R. W. Finberg.
1997.
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.
Science
275:1320-1323 |
| 4. | Boudin, M.-L., and P. Boulanger. 1981. Antibody-triggered dissociation of adenovirus penton capsomer. Virology 113:781-786[CrossRef][Medline]. |
| 5. | Boudin, M.-L., and P. Boulanger. 1982. Assembly of adenovirus penton base and fiber. Virology 116:589-604[CrossRef][Medline]. |
| 6. | Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810[Abstract]. |
| 7. | Chroboczek, J., R. W. Ruigrok, and S. Cusack. 1995. Adenovirus fiber. Curr. Top. Microbiol. Immunol. 199:163-200. |
| 8. |
Dmitriev, I.,
V. Krasnykh,
C. R. Miller,
M. Wang,
E. Kashentseva,
G. Mikheeva,
N. Belousova, and D. T. Curiel.
1998.
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
J. Virol.
72:9706-9713 |
| 9. | Douglas, J. T., B. E. Rogers, M. E. Rosenfeld, S. I. Michael, M. Feng, and D. T. Curiel. 1996. Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14:1574-1578[CrossRef][Medline]. |
| 10. | Ebbinghaus, S. W., N. Vigneswaran, C. R. Miller, R. A. Chee-Awai, C. A. Mayfield, D. T. Curiel, and D. M. Miller. 1996. Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes. Gene Ther. 3:287-297[Medline]. |
| 11. |
Graham, F. L.,
J. Smiley,
W. C. Russell, and R. Nairn.
1977.
Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
J. Gen. Virol.
36:59-74 |
| 12. |
He, T. C.,
S. Zhou,
L. T. da Costa,
J. Yu,
K. W. Kinzler, and B. Vogelstein.
1998.
A simplified system for generating recombinant adenoviruses.
Proc. Natl. Acad. Sci. USA
95:2509-2514 |
| 13. |
Hong, J. S., and J. A. Engler.
1996.
Domains required for assembly of adenovirus type 2 fiber trimers.
J. Virol.
70:7071-7078 |
| 14. | Hong, S. S., and P. Boulanger. 1995. Protein ligands of the human adenovirus type 2 outer capsid identified by biopanning of a phage-displayed peptide library on separate domains of wild-type and mutant penton capsomers. EMBO J. 14:4714-4727[Medline]. |
| 15. | Hong, S. S., A. Galaup, R. Peytavi, N. Chazal, and P. Boulanger. 1999. Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity. Hum. Gene Ther. 10:2577-2586[CrossRef][Medline]. |
| 16. |
Hong, S. S.,
L. Karayan,
J. Tournier,
D. T. Curiel, and P. A. Boulanger.
1997.
Adenovirus type 5 fiber knob binds to MHC class I 2 domain at the surface of human epithelial and B lymphoblastoid cells.
EMBO J.
16:2294-2306[CrossRef][Medline].
|
| 17. | Hoppe, H. J., P. N. Barlow, and K. B. Reid. 1994. A parallel three stranded alpha-helical bundle at the nucleation site of collagen triple-helix formation. FEBS Lett. 344:191-195[CrossRef][Medline]. |
| 18. | Huvent, I., S. S. Hong, C. Fournier, B. Gay, J. Tournier, C. Carrière, M. Courcoul, R. Vigne, B. Spire, and P. Boulanger. 1998. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. J. Gen. Virol. 79:1069-1081[Abstract]. |
| 19. | Karayan, L., B. Gay, J. Gerfaux, and P. Boulanger. 1994. Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells. Virology 202:782-795[CrossRef][Medline]. |
| 20. | Karayan, L., S. S. Hong, B. Gay, J. Tournier, A. Dupuy d'Angeac, and P. Boulanger. 1997. Structural and functional determinants in adenovirus type 2 penton base recombinant protein. J. Virol. 71:8678-8689[Abstract]. |
| 21. |
Kirby, I.,
E. Davison,
A. J. Beavil,
C. P. Soh,
T. J. Wickham,
P. W. Roelvink,
I. Kovesdi,
B. J. Sutton, and G. Santis.
1999.
Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR.
J. Virol.
73:9508-9514 |
| 22. |
Krasnykh, V. N.,
G. V. Mikheeva,
J. T. Douglas, and D. T. Curiel.
1996.
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.
J. Virol.
70:6839-6846 |
| 23. |
Legrand, V.,
D. Spehner,
Y. Schlesinger,
N. Settelen,
A. Pavirani, and M. Mehtali.
1999.
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.
J. Virol.
73:907-919 |
| 24. |
Louis, N.,
P. Fender,
A. Barge,
P. Kitts, and J. Chroboczek.
1994.
Cell-binding domain of adenovirus serotype 2 fiber.
J. Virol.
68:4104-4106 |
| 25. | Michael, S. I., J. S. Hong, D. T. Curiel, and J. A. Engler. 1995. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2:660-668[Medline]. |
| 26. |
Mullis, K. G.,
R. S. Haltiwanger,
G. W. Hart,
R. B. Marchase, and J. A. Engler.
1990.
Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins.
J. Virol.
64:5317-5323 |
| 27. | Novelli, A., and P. Boulanger. 1991. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365-376[CrossRef][Medline]. |
| 28. |
Oliner, J. D.,
K. W. Kinzler, and B. Vogelstein.
1993.
In vivo cloning of PCR products in E. coli.
Nucleic Acids Res.
21:5192-5197 |
| 29. | O'Reilly, D., L. Miller, and V. Luckow. 1994. Baculovirus expression vectors: a laboratory manual. Oxford University Press Inc, New York, N.Y. |
| 30. | Pasqualini, R., E. Koivunen, and E. Ruoslahti. 1997. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15:542-546[CrossRef][Medline]. |
| 31. |
Roelvink, P. W.,
A. Lizonova,
J. G. Lee,
Y. Li,
J. M. Bergelson,
R. W. Finberg,
D. E. Brough,
I. Kovesdi, and T. J. Wickham.
1998.
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F.
J. Virol.
72:7909-7915 |
| 32. | Rogers, B. E., J. T. Douglas, C. Ahlem, D. J. Buchsbaum, J. Frincke, and D. T. Curiel. 1997. Use of a novel cross-linking method to modify adenovirus tropism. Gene Ther. 4:1387-1392[CrossRef][Medline]. |
| 33. | Ruigrok, R. W., A. Barge, C. Albiges-Rizo, and S. Dayan. 1990. Structure of adenovirus fibre. II. Morphology of single fibres. J. Mol. Biol. 215:589-596[CrossRef][Medline]. |
| 34. | Ruoslahti, E. 1996. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:697-715[CrossRef][Medline]. |
| 35. | Santis, G., V. Legrand, S. S. Hong, E. Davison, I. Kirby, J. L. Imler, R. W. Finberg, J. M. Bergelson, M. Mehtali, and P. Boulanger. 1999. Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR J. Gen. Virol. 80:1519-1527[Abstract]. |
| 36. | Schoen, G., P. Fender, J. Chroboczek, and E. A. Hewat. 1996. Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding. EMBO J. 15:6841-6846[Medline]. |
| 37. | Shafren, D. R., D. T. Williams, and R. D. Barry. 1997. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71:9844-9848[Abstract]. |
| 38. |
Shayakhmetov, D. M., and A. Lieber.
2000.
Dependence of adenovirus infectivity on length of the fiber shaft domain.
J. Virol.
74:10274-10286 |
| 39. | Stouten, P. F. W., C. Sander, R. W. H. Ruigrok, and S. Cusack. 1992. A new triple-helical model for the shaft of the adenovirus fibre. J. Mol. Biol. 226:1073-1084[CrossRef][Medline]. |
| 40. | Van Beusechem, V. W, A. L. C. T. van Rijswijk, H. H. G. van Es, H. J. Haisma, H. M. Pinebo, and W. R. Gerritsen. 2000. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer. Gene Ther. 22:1940-1946. |
| 41. |
Vigne, E.,
I. Mahfouz,
J. F. Dedieu,
A. Brie,
M. Perricaudet, and P. Yeh.
1999.
RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection.
J. Virol.
73:5156-5161 |
| 42. |
Von Seggern, D. J.,
C. Y. Chiu,
S. K. Fleck,
P. L. Stewart, and G. R. Nemerow.
1999.
A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.
J. Virol.
73:1601-1608 |
| 43. | Wickham, T. J., M. E. Carrion, and I. Kovesdi. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2:750-756[Medline]. |
| 44. | Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319[CrossRef][Medline]. |
| 45. | Wickham, T. J., E. Tzeng, L. L. Shears, 2nd, P. W. Roelvink, Y. Li, G. M. Lee, D. E. Brough, A. Lizonova, and I. Kovesdi. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71:8221-8229[Abstract]. |
| 46. |
Wilson, J. M.
1996.
Adenoviruses as gene-delivery vehicles.
N. Engl. J. Med.
334:1185-1187 |
This article has been cited by other articles: